Skip to main content
. 2017 Mar 13;8(18):30369–30382. doi: 10.18632/oncotarget.16153

Figure 2. In vitro release of curcumin (CUR) and paclitaxel (PTX) in 0.1 % (w/v) Tween 80 solution (n=3, mean ± SD).

Figure 2

(A), FPCN; (B), FPCHN-10; (C), FPCHN-30; (D), FPCHN-50.